Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Kägebein D"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lehmann, J., Kluike, C. W., Haider, A., Haider, K. S, Baumann, S., Flesch, M., Gedamke, M., Kägebein, D.
Publikováno v:
Der Urologe A; Feb2022, Vol. 61 Issue 2, p173-182, 10p
Autor:
Lehmann J; Urologische Gemeinschaftspraxis Prüner Gang, Gesundheitszentrum Kiel-Mitte, Prüner Gang 15., 24103, Kiel, Deutschland. lehmannkiel@arcor.de., Kluike CW; Urologie am Wasserturm, Lüneburg, Deutschland., Haider A; Praxis für Urologie und Andrologie, Bremerhaven, Deutschland., Haider KS; Praxis für Urologie und Andrologie, Bremerhaven, Deutschland., Baumann S; Praxisgemeinschaft für Urologie, Leipzig, Deutschland., Flesch M; Marienkrankenhaus, Soest, Deutschland., Gedamke M; msc, Kiel, Deutschland., Kägebein D; Ferring Arzneimittel GmbH, Kiel, Deutschland.
Publikováno v:
Der Urologe. Ausg. A [Urologe A] 2022 Feb; Vol. 61 (2), pp. 173-182. Date of Electronic Publication: 2021 Aug 17.
Autor:
Delacher M; Chair for Immunology, University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Schmidl C; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany., Herzig Y; Department of Immunology, Weizmann Institute of Science, 234 Herzl Street, 76100, Rehovot, Israel., Breloer M; Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Straße 74, 20359, Hamburg, Germany., Hartmann W; Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Straße 74, 20359, Hamburg, Germany., Brunk F; Division of Developmental Immunology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Kägebein D; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Träger U; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hofer AC; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Bittner S; Chair for Immunology, University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany., Weichenhan D; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hotz-Wagenblatt A; Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Breiling A; Division of Epigenetics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Federico G; Division of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Gröne HJ; Division of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Schmid RM; Department of Internal Medicine, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany., Rehli M; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany., Abramson J; Department of Immunology, Weizmann Institute of Science, 234 Herzl Street, 76100, Rehovot, Israel., Feuerer M; Chair for Immunology, University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. markus.feuerer@ukr.de.; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. markus.feuerer@ukr.de.; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. markus.feuerer@ukr.de.
Publikováno v:
Nature communications [Nat Commun] 2019 Apr 08; Vol. 10 (1), pp. 1621. Date of Electronic Publication: 2019 Apr 08.
Autor:
Delacher M, Imbusch CD, Weichenhan D, Breiling A, Hotz-Wagenblatt A, Träger U, Hofer AC, Kägebein D, Wang Q, Frauhammer F, Mallm JP, Bauer K, Herrmann C, Lang PA, Brors B, Plass C, Feuerer M
Publikováno v:
Nature immunology [Nat Immunol] 2017 Nov 16; Vol. 18 (12), pp. 1361.
Autor:
Delacher M; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Weichenhan D; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Breiling A; Division of Epigenetics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hotz-Wagenblatt A; Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany., Träger U; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hofer AC; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kägebein D; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Wang Q; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Frauhammer F; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mallm JP; Research Group Genome Organization &Function, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg, Germany., Bauer K; Heidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg, Germany., Herrmann C; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lang PA; Department of Molecular Medicine II, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Brors B; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Plass C; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Feuerer M; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Immunology, Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Regensburg, Germany.
Publikováno v:
Nature immunology [Nat Immunol] 2017 Oct; Vol. 18 (10), pp. 1160-1172. Date of Electronic Publication: 2017 Aug 07.
Autor:
Radomski N; Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Südufer 10, D-17493, Greifswald, Isle of Riems, Germany., Kägebein D; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany., Liebler-Tenorio E; Institute of Molecular Pathogenesis, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Naumburger Strasse 96a, D-07743, Jena, Germany., Karger A; Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Südufer 10, D-17493, Greifswald, Isle of Riems, Germany., Rufer E; Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Südufer 10, D-17493, Greifswald, Isle of Riems, Germany., Tews BA; Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Südufer 10, D-17493, Greifswald, Isle of Riems, Germany., Nagel S; German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany., Einenkel R; Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Südufer 10, D-17493, Greifswald, Isle of Riems, Germany., Müller A; University of Tübingen, Interfaculty Institute of Biochemistry, Hoppe-Seyler-Strasse 4, D-72076, Tübingen, Germany., Rebbig A; Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Südufer 10, D-17493, Greifswald, Isle of Riems, Germany., Knittler MR; Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Südufer 10, D-17493, Greifswald, Isle of Riems, Germany. michael.knittler@fli.de.
Publikováno v:
Scientific reports [Sci Rep] 2017 Jun 20; Vol. 7 (1), pp. 3923. Date of Electronic Publication: 2017 Jun 20.
Autor:
Kyoko Kobayashi1 k-kyoko@tohoku-mpu.ac.jp, Kenroh Sasaki1
Publikováno v:
Drug Discoveries & Therapeutics. Feb2024, Vol. 18 Issue 1, p24-33. 10p.
Autor:
Rufer E; Institute of Immunology, Federal Research Institute of Animal Health, Friedrich Loeffler Institute, D-17493 Greifswald-Isle of Riems, Germany;, Kägebein D; Institute of Immunology, Federal Research Institute of Animal Health, Friedrich Loeffler Institute, D-17493 Greifswald-Isle of Riems, Germany;, Leonhardt RM; Howard Hughes Medical Institute, New Haven, CT 06519; and Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06519., Knittler MR; Institute of Immunology, Federal Research Institute of Animal Health, Friedrich Loeffler Institute, D-17493 Greifswald-Isle of Riems, Germany; michael.knittler@fli.bund.de.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2015 Dec 01; Vol. 195 (11), pp. 5482-94. Date of Electronic Publication: 2015 Oct 30.
Autor:
Richards DM; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Delacher M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Goldfarb Y; Faculty of Biology, Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Kägebein D; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hofer AC; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Abramson J; Faculty of Biology, Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Feuerer M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: m.feuerer@dkfz.de.
Publikováno v:
Progress in molecular biology and translational science [Prog Mol Biol Transl Sci] 2015; Vol. 136, pp. 175-205. Date of Electronic Publication: 2015 Aug 18.